You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
興齊眼藥(300573.SZ):擬出售上海康恩德100%股權及其眼科醫療器械業務相關資產等
格隆匯 07-09 16:33

格隆匯7月9日丨興齊眼藥(300573.SZ)公佈,202179日,公司第四屆董事會第次會議,審議通過了《關於公司出售全資子公司股權及部分資產暨關聯交易的議案》。

同日,公司海南科升投資控股有限公司(“海南科升”)上海康恩德醫療科技有限公司(“上海康恩德”或“標的公司”)簽署了《股權及資產轉讓協議》,擬將全資子公司上海康恩德100%的股權與標的公司眼科醫療器械業務相關的資(“標的資產”)以及與標的資產相關的正在履行的合同(“待轉移合同”)3316.49萬元人民幣轉讓給海南科升其指定方

公司控股股東、實際控制人劉繼東持有海南科升100%股權劉繼東與公司董事劉高志系父子關係。根據《深圳證券交易所創業板股票上市規則》及《瀋陽興齊眼藥股份有限公司章程》的相關規定,此次交易事項構成關聯交易。

上海康恩德系公司於20191231日出資設立,主要業務圍繞眼科醫療器械領域開展2020年度實現營業收入483,185.90元,實現淨利潤-5,073,962.06元。眼科醫療器械項目研發投入資金量大、變現週期長公司通過此次交易優化公司資源配置,公司資產質量,聚焦眼科藥物領域,公司核心競爭力,符合公司整體戰略規劃及實際經營需要,不存在損害公司及股東,特別是中小股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account